Toon Digneffe | Head, Public Affairs & Public Policy, Europe & Canada

Toon Digneffe, Head, Public Affairs & Public Policy, Europe & Canada, Takeda

Toon Digneffe Head of Public Affairs & Public Policy - Europe & Canada at Takeda   Toon Digneffe is Head of Public Affairs & Public Policy Europe & Canada at Takeda. He has over 25 years’ experience in government affairs, communications, market access and patient advocacy at local, regional and global level.   Mr Digneffe has extensive experience in pharmaceutical industry, as he has been working in the sector since 2002 after having spent time in the European Commission and Consultancy (Fleishman-Hillard) at the early start of his career. He worked as Head of Public Affairs for Shire since 2016, before its acquisition from Takeda. Previously, he worked for Baxter International for over 13 years, and for Baxalta, with roles of increasing responsibility at local, regional and global level. Since 2018, Toon serves as Executive Board member of the European Industry Association EUCOPE.   Toon holds a Master in Political Science from the University of Leuven, Belgium/ University of Leicester, England and a Post-Graduate Degree in European Studies from the College of Europe, Bruges, Belgium. He is co-author of the book by Martin Westlake, “the Council of the European Union”, John Harper publishing.


Day 1 - Wednesday 23 October @ 08:40

Opening keynote address: How will the current OMP amendments effect orphan drug development and patient access?

-How should industry respond in order to keep innovating more therapies for rare diseases?

-How will the pharmaceutical legislation affect R&D in rare diseases, regulation, affordability and accessibility to patients?

-How should each multi-s-takeholder interpret and act upon the proposal and changes in order to gain a more sustainable ecosystem?

-How can we boost research and development to tackle rare diseases and develop orphan medicines?

last published: 04/Jul/24 16:55 GMT

back to speakers